Clinical trial
REAL PTX - Randomized Evaluation of the Zilver PTX Stent vs. Paclitaxel-Eluting Balloons for Treatment of Symptomatic Peripheral Artery Disease of the Femoropopliteal Artery
NCT01728441 is registered in ClinicalTrials.gov with Provascular GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- REAL PTX - Randomized Evaluation of the Zilver PTX Stent vs. Paclitaxel-Eluting Balloons for Treatment of Symptomatic Peripheral Artery Disease of the Femoropopliteal Artery
- Lead sponsor
- Provascular GmbH
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2012
- Completion date
- May 31, 2014
- Enrollment
- 150 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
peripheral artery disease